Menu
On October 7, 2020, Dr. Danielli, the head of the Optical Imaging and Biosensing Laboratory at Bar Ilan University, presented to the Israeli Minister of Health, Mr. Yuli-Yoel Edelstein the MMB platform for rapid and sensitive detection of the SARS-CoV-2. The small footprint MMB platform (located to Mr. Edelstein’s left) was developed by MagBiosense, who comecalizes the MMB technology worldwide. The presentation was held at the Center for Digital Innovation in Sheba Medical Center at Tel HaShomer. Watch video
Dozens of laboratory directors, cardiologists, internal medicine physicians, clinical chemists, and biomedical engineers visited Bar-Ilan University in late September for a three-day symposium on innovative high-sensitivity cardiac troponin and other cardiac biomarkers testing. The distinguished guests included, Prof. Allan Jaffe, Prof. Fred Apple, Prof. Jack Ladenson, Prof. Johannes Mair, and Prof. Kristian Thygesen. The symposium organizer, Dr. Amos Danielli, presented MagBiosense’s technology and the recent results of its cardiac troponin assay. The symposium was held under the auspice of the International Federation of Clinical Chemistry and The European Federation of Clinical Chemistry and Laboratory Medicine, and sponsored by the major manufacturing companies in this field.
A recent study done by Magbiosense was featured on the inside front cover of Small The paper, entitled ‘Photobleaching: Improving the Sensitivity of Fluorescence‐Based Immunoassays by Photobleaching the Autofluorescence of Magnetic Beads’, can be found in the Publications section, and at DOI: 10.1002/smll.201970016.
MagBiosense and The Central Virology Laboratory of Israel signed a leasing agreement for the use of the MMB platform in the detection of Zika virus in patients.
Since joining Bar Ilan University’s School of Engineering in 2014, Dr. Amos Danielli is exploring new medical applications for the novel technology he developed, which can help shorten diagnosis time for heart patients. BIU published a short article about the technology, which is currently being developed through a collaborative effort with MagBiosense. To read the full article please visit here
The Israeli Advanced Technology Industries (IATI) selected MagBiosense to present in the Biomed 2016 startup competition that takes place in Tel Aviv, Israel. The competition will set MagBiosense among few of the top startup companies to emerge from the life sciences and high-tech academia in Israel. To learn more, please visit the following links:
In Hebrew: nana10 news article
IATI Biomed 2016: http://kenes-exhibitions.com/biomed2016/
Israeli financial and business newspaper Globes published an article about the technology developed by MagBiosense. To see the article, please visit: http://www.globes.co.il/en/article-magbiosense IATI Biomed 2016: http://www.globes.co.il/en/article-magbiosense
On December 16, 2015 the Israel-US BIRD (Binational Industrial R&D) Foundation named MagBiosense as a recipient of a $900,000 investment award. The funding was awarded for the development of a high sensitivity, point-of-care device for heart attack detection in the Emergency Departments. MagBiosense has partnered with the BDR Group to complete the project. Read more about it here: BIRD – Israel-U.S. Binational Industrial R&D Foundation to Invest $7.5 Million in 9 New Projects and here MagBioSense, Forrest Innovations each get $1 million grants through Israeli partnership.
MagBiosense went on the KMOX 1120 show “Nothing Impossible” to talk with Travis Sheridan and Debbie Monterrey about their exciting technology.
As winners of the Accelerate St. Louis Challenge, MagBiosense scientist Orr Hadass and senior scientist Dr. Jasenka Verbarg were interviewed by the Stay Tuned show on the Nine Network.
MagBiosense won the Bright Futures Diversity Award from St. Louis Mosaic for the Most Promising Immigrant-Owned Company. This award was part of the Accelerate St. Louis Challenge – a challenge for the best local startups. The rewards include strings-attached cash, top-tier professional services, new office space, and an opportunity to compete in front of St. Louis’ startup community.
MagBiosense was announced as the 1st place winner of the Accelerate St. Louis Challenge 2015 at the 2015 Startup Connection, The event was held at Washington University in St. Louis and showcased 70 up-and-coming startup companies. Accelerate St. Louis is a regional effort to showcase the startup explosion reshaping the region. The Accelerate St. Louis Challenge included a detailed business plan application, presentation to a panel of expert judges, and a video pitch submission.
See more here: Five companies win Accelerate St. Louis prize
A microscope in a needle, a handheld device that prescribes corrective eyeglasses, and a device for heart attack diagnosis are winning projects in the 2014 SPIE Startup Challenge Hosted by SPIE, the international society for optics and photonics, the pitch competition was held early this month in San Francisco during SPIE Photonics West See more at: http://www.prweb.com/releases/2014/02/prweb11600983.htm
Arch Grants, the global business startup competition that provides $50,000 non-dilutive grants to early stage ventures, today announces the 2013 Global Startup Competition winners. Arch Grants created the competition to help grow businesses and create a more robust entrepreneurial culture and infrastructure in St.Louis.
See more at: http://archgrants.org/2013/05/2013-arch-grants-competition-winners-announcement/
A startup that has invented and patented a new way to detect the bio-markers of a heart attack, won first place at the Olin Cup, a business plan competition at Washington University in St. Louis. MMBiosensing won $70,000 in seed funding in the competition, which is organized by the Skandalaris Center for Entrepreneurial Studies. See more at: http://www.bizjournals.com/stlouis/blog/BizNext/2013/01/startup-developing-test-for-heart.html